Traditional antibody discovery procedures are often limited by the ... anticancer activity in combination with anti-PD1 antibody therapy; and Sym023, a unique anti-TIM3 antibody with a novel ...

Ablexis, LLC, developer of the AlivaMab Mouse and AlivaMab Discovery Services, LLC, offer customized and streamlined solutions for companies and organizations looking to obtain efficacious and ...

while being able to culture the B-cells with standard procedures. This allows for the isolation of therapeutic antibodies from rare B-cell clones, and accelerated functional screening and ...

In blood cancers such as chronic lymphocytic leukemia, B cells of the immune system multiply uncontrollably. One form of ...

We offer a comprehensive suite of immune checkpoint-related products, including high-quality proteins, inhibitor screening ...

Immune checkpoint blockade antibodies, such as ipilimumab, are considered another therapeutic strategy against cancer due to their different mode of the antitumor mechanism and they have recently ...